Results 261 to 270 of about 9,647,508 (315)

Alpinetin Nanoparticles Alleviate Optic Nerve Injury Induced by Acute Glaucoma via LRP1‐PPARγ Mediated Regulation of Microglial Lipid Metabolism

open access: yesAdvanced Science, EarlyView.
Microglial lipid metabolic dysfunction drives neurodegeneration in glaucoma. We found loss of LRP1 causes lipid accumulation and inflammation. We developed alpinetin‐loaded nanoparticles (AlpNPs) that bind LRP1, activate the PPARγ‐LXRα‐ABCA1 pathway to restore lipid homeostasis, promote an anti‐inflammatory phenotype, and protect retinal ganglion cells,
Miao Wei   +8 more
wiley   +1 more source

New horizons for Parkinson's disease treatment? [PDF]

open access: yesLancet Reg Health Am
The Lancet Regional Health-Americas.
europepmc   +1 more source

PRKN/PINK1 Mutations in a Chinese Patient With Early-Onset Parkinson's Disease. [PDF]

open access: yesBrain Behav
Lu Z   +8 more
europepmc   +1 more source

Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trial

open access: diamond
Joaquim J. Ferreira   +7 more
openalex   +1 more source

MRI Epicenters Differentiate Spatiotemporal Patterns of Neurodegeneration in Parkinson's Disease. [PDF]

open access: yesAdv Sci (Weinh)
Duanmu X   +23 more
europepmc   +1 more source

Metabolic Parkinson's disease. [PDF]

open access: yesFront Aging Neurosci
Invernizzi F   +8 more
europepmc   +1 more source

Presence of Tissue Transglutaminase in Granular Endoplasmic Reticulum is Characteristic of Melanized Neurons in Parkinson's Disease Brain

open access: green, 2010
Micha M.M. Wilhelmus   +7 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy